Cancer
Only 1 of 25 cancer drug developers fairly included minority patients over five-year window, BMJ analysis finds
New clinical trial diversity plans, which FDA will soon explain further, were featured in the government spending package that President Joe Biden ...
Neighborhood segregation and cancer prevention guideline adherence in US Hispanic/Latino adults: Results from the HCHS/SOL
Background:
Adherence to the American Cancer Society (ACS) guidelines for cancer prevention is associated with a lower risk of cance...
The association of race/ethnicity in male breast cancer survival within similar comorbidity cohorts
Background:
Concomitant disease is associated with poor breast cancer survival in women and is more prevalent in racial/ethnic minor...
How Structural Racism Affects Triple-Negative Breast Cancer Risk
Some choices – such as whether you exercise, smoke, or drink – can affect your health. But there aren’t many known risk factors for triple-negative...
Exploring cancer care needs for Latinx adults: a qualitative evaluation
Purpose:
Latinx adults with cancer, as compared with non-Latinx White adults, are diagnosed with more advanced stages and experience...
Health-Related Quality of Life by Race, Ethnicity, and Country of Origin among Cancer Survivors
Background:
Typical cancer research studies of health-related quality of life (HRQOL) in the United States do not include country of...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
